Evidence map›Paper›PMID 39660034›Full record

ReviewAPL bioengineering2024

Advancing hyperspectral imaging and machine learning tools toward clinical adoption in tissue diagnostics: A comprehensive review.

Chun-Liang Lai, Riya Karmakar, Arvind Mukundan, Ragul Kumar Natarajan, Song-Cun Lu, Cheng-Yi Wang, Hsiang-Chen Wang

Abstract readReview
In one paragraph

Review in APL bioengineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Riya KarmakarDepartment of Mechanical Engineering, National Chung Cheng University, 168, University Road, Min Hsiung, Chiayi City 62102, Taiwan.ORCID https://orcid.org/0000-0003-0762-6770
Arvind MukundanDepartment of Mechanical Engineering, National Chung Cheng University, 168, University Road, Min Hsiung, Chiayi City 62102, Taiwan.ORCID https://orcid.org/0000-0002-7741-3722
Ragul Kumar NatarajanDepartment of Biotechnology, Karpagam Academy of Higher Education, Salem - Kochi Hwy, Eachanari, Coimbatore, Tamil Nadu 641021, India.ORCID https://orcid.org/0009-0000-4381-1987
Song-Cun LuDepartment of Mechanical Engineering, National Chung Cheng University, 168, University Road, Min Hsiung, Chiayi City 62102, Taiwan.ORCID https://orcid.org/0009-0000-3234-7891
Cheng-Yi WangDepartment of Gastroenterology, Kaohsiung Armed Forces General Hospital, 2, Zhongzheng 1st. Rd., Kaohsiung City 80284, Taiwan.ORCID https://orcid.org/0000-0002-3698-8319
Hsiang-Chen WangDepartment of Mechanical Engineering, National Chung Cheng University, 168, University Road, Min Hsiung, Chiayi City 62102, Taiwan.ORCID https://orcid.org/0000-0003-4107-2062

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperspectral imaging (HSI) has become an evident transformative apparatus in medical diagnostics. The review aims to appraise the present advancement and challenges in HSI for medical applications. It features a variety of medical applications namely diagnosing diabetic retinopathy, neurodegenerative diseases like Parkinson's and Alzheimer's, which illustrates its effectiveness in early diagnosis, early caries detection in periodontal disease, and dermatology by detecting skin cancer. Regardless of these advances, the challenges exist within every aspect that limits its broader clinical adoption. It has various constraints including difficulties with technology related to the complexity of the HSI system and needing specialist training, which may act as a drawback to its clinical settings. This article pertains to potential challenges expressed in medical applications and probable solutions to overcome these constraints. Successful companies that perform advanced solutions with HSI in terms of medical applications are being emphasized in this study to signal the high level of interest in medical diagnosis for systems to incorporate machine learning ML and artificial intelligence AI to foster precision diagnosis and standardized clinical workflow. This advancement signifies progressive possibilities of HSI in real-time clinical assessments. In conclusion despite HSI has been presented as a significant advanced medical imaging tool, addressing its limitations and probable solutions is for broader clinical adoption.

Identifiers

PMID39660034
PMCPMC11629177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.